beta-globin restored autologous hematopoietic stem cell therapy (Shanghai Bioray Laboratory)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namebeta-globin restored autologous hematopoietic stem cell therapy (Shanghai Bioray Laboratory)
Drug Alias Namebeta-globin restored autologous HSC (Shanghai Bioray Laboratory)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionHemoglobin beta chain modulators
TargetsHemoglobin beta chain
Therapy Area/IndicationsThalassemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesBRL Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesBRL Medicine Inc
Inactive CompaniesN/A
Active IndicationsThalassemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A